Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

33.71  +0.46 (+1.38%)

After market: 33.71 0 (0%)

Fundamental Rating

6

Overall BLBD gets a fundamental rating of 6 out of 10. We evaluated BLBD against 128 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on BLBD. With these ratings, BLBD could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
In the past year BLBD had a positive cash flow from operations.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 20.20%, BLBD belongs to the top of the industry, outperforming 97.66% of the companies in the same industry.
BLBD's Return On Equity of 60.16% is amongst the best of the industry. BLBD outperforms 98.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 30.58%, BLBD belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
Industry RankSector Rank
ROA 20.2%
ROE 60.16%
ROIC 30.58%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLBD has a Profit Margin of 8.05%. This is in the better half of the industry: BLBD outperforms 64.06% of its industry peers.
BLBD's Profit Margin has improved in the last couple of years.
BLBD has a Operating Margin of 10.01%. This is comparable to the rest of the industry: BLBD outperforms 51.56% of its industry peers.
In the last couple of years the Operating Margin of BLBD has grown nicely.
BLBD has a Gross Margin of 18.83%. This is in the lower half of the industry: BLBD underperforms 75.00% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.01%
PM (TTM) 8.05%
GM 18.83%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
Compared to 1 year ago, BLBD has more shares outstanding
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.44 indicates that BLBD is not in any danger for bankruptcy at the moment.
The Altman-Z score of BLBD (5.44) is better than 81.25% of its industry peers.
BLBD has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
BLBD's Debt to FCF ratio of 0.78 is amongst the best of the industry. BLBD outperforms 88.28% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that BLBD is not too dependend on debt financing.
BLBD's Debt to Equity ratio of 0.49 is in line compared to the rest of the industry. BLBD outperforms 46.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 0.78
Altman-Z 5.44
ROIC/WACC3
WACC10.18%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.44. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, BLBD is doing worse than 75.78% of the companies in the same industry.
BLBD has a Quick Ratio of 1.44. This is a bad value and indicates that BLBD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.73, BLBD is not doing good in the industry: 83.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.07%, which is quite impressive.
BLBD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
Looking at the last year, BLBD shows a quite strong growth in Revenue. The Revenue has grown by 10.59% in the last year.
Measured over the past years, BLBD shows a small growth in Revenue. The Revenue has been growing by 5.74% on average per year.
EPS 1Y (TTM)53.07%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%1.1%
Revenue 1Y (TTM)10.59%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%-1.17%

3.2 Future

BLBD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.60% yearly.
The Revenue is expected to grow by 6.51% on average over the next years.
EPS Next Y16.13%
EPS Next 2Y14.42%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue Next Year8.35%
Revenue Next 2Y8.13%
Revenue Next 3Y6.51%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.66, the valuation of BLBD can be described as reasonable.
Based on the Price/Earnings ratio, BLBD is valued cheaply inside the industry as 89.84% of the companies are valued more expensively.
BLBD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 7.40, the valuation of BLBD can be described as very cheap.
95.31% of the companies in the same industry are more expensive than BLBD, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, BLBD is valued rather cheaply.
Industry RankSector Rank
PE 9.66
Fwd PE 7.4
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLBD is valued cheaper than 83.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLBD is valued cheaper than 91.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.99
EV/EBITDA 6.96
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.6
PEG (5Y)0.59
EPS Next 2Y14.42%
EPS Next 3Y8.6%

0

5. Dividend

5.1 Amount

No dividends for BLBD!.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (4/17/2025, 8:04:15 PM)

After market: 33.71 0 (0%)

33.71

+0.46 (+1.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners112.01%
Inst Owner Change0.06%
Ins Owners0.09%
Ins Owner Change8.66%
Market Cap1.08B
Analysts83.08
Price Target54.06 (60.37%)
Short Float %19.33%
Short Ratio8.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.89%
Min EPS beat(2)10.53%
Max EPS beat(2)15.25%
EPS beat(4)4
Avg EPS beat(4)44.95%
Min EPS beat(4)10.53%
Max EPS beat(4)79.91%
EPS beat(8)8
Avg EPS beat(8)80.6%
EPS beat(12)9
Avg EPS beat(12)-112.02%
EPS beat(16)10
Avg EPS beat(16)-88.76%
Revenue beat(2)1
Avg Revenue beat(2)1.84%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)4.2%
Min Revenue beat(4)-0.54%
Max Revenue beat(4)13.65%
Revenue beat(8)6
Avg Revenue beat(8)6.42%
Revenue beat(12)9
Avg Revenue beat(12)8.73%
Revenue beat(16)10
Avg Revenue beat(16)4.38%
PT rev (1m)0%
PT rev (3m)-6.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.65%
EPS NY rev (1m)0%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 9.66
Fwd PE 7.4
P/S 0.81
P/FCF 8.99
P/OCF 7.88
P/B 6.02
P/tB 9.19
EV/EBITDA 6.96
EPS(TTM)3.49
EY10.35%
EPS(NY)4.56
Fwd EY13.52%
FCF(TTM)3.75
FCFY11.12%
OCF(TTM)4.28
OCFY12.68%
SpS41.84
BVpS5.6
TBVpS3.67
PEG (NY)0.6
PEG (5Y)0.59
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 60.16%
ROCE 43.96%
ROIC 30.58%
ROICexc 55.11%
ROICexgc 86.77%
OM 10.01%
PM (TTM) 8.05%
GM 18.83%
FCFM 8.96%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.51
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 0.78
Debt/EBITDA 0.59
Cap/Depr 112.59%
Cap/Sales 1.26%
Interest Coverage 12.81
Cash Conversion 91.86%
Profit Quality 111.31%
Current Ratio 1.44
Quick Ratio 0.73
Altman-Z 5.44
F-Score8
WACC10.18%
ROIC/WACC3
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.07%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%1.1%
EPS Next Y16.13%
EPS Next 2Y14.42%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue 1Y (TTM)10.59%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%-1.17%
Revenue Next Year8.35%
Revenue Next 2Y8.13%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
EBIT growth 1Y34.93%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year38.79%
EBIT Next 3Y15.18%
EBIT Next 5YN/A
FCF growth 1Y433.95%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y380.59%
OCF growth 3YN/A
OCF growth 5Y14.81%